The effects of aerobic training along with spirulina supplementation in women with overweight and obesity

The effects of aerobic training along with spirulina supplementation on markers of hepatic, cardiovascular, lipid profile and anthropometric indices in women with overweight and obesity

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210103049933N1

Enrollment

Registered

2021-05-19

Start date

2021-05-22

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity. Overweight and obesity

Interventions

Intervention 1: Intervention group1: Three capsules 500 mg/d of spirulina after each meal for 8 weeks (Made by the German Rocket company ). Intervention 2: Control group: Three capsules 500 mg/d conta

Eligibility

Sex/Gender

Female

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Women between 20 to 50 years old Body mass index (BMI) between 25 to 35 (kg / m2)

Exclusion criteria

Exclusion criteria: Use of other dietary supplements, probiotics and anti-inflammatory drugs Use of any antioxidant supplements in the last 3 months Use of immunosuppressive drugs Following of special diets Pregnancy, lactation Smokers Menopause Having a history of diabetes, cancer, liver, kidney, thyroid and gastrointestinal diseases

Design outcomes

Primary

Measure	Time frame
Weight. Timepoint: Before and after the intervention. Method of measurement: Seca scale.;Body mass index. Timepoint: Before and after the intervention. Method of measurement: Weight divided by the square of height in meters (kg / m2).;Waist and hip circumference. Timepoint: Before and after the intervention. Method of measurement: Tape metre (cm).;Liver enzymes (alanine aminotransferase, aspartate aminotransferase and gamma glutamyl transferase). Timepoint: Before and after the intervention. Method of measurement: Colorimetric enzymatic method (Pars Azmun).;Lipid profile (HDL-c, LDL-c, TG, total cholesterol and VLDL). Timepoint: Before and after the intervention. Method of measurement: Colorimetric enzymatic method (Pars Azmun).;Serum homocysteine. Timepoint: Before and after the intervention. Method of measurement: ELISA.;Serum levels of C-reactive protein. Timepoint: Before and after the intervention. Method of measurement: ELISA.	—

Measure

Time frame

Weight. Timepoint: Before and after the intervention. Method of measurement: Seca scale.;Body mass index. Timepoint: Before and after the intervention. Method of measurement: Weight divided by the square of height in meters (kg / m2).;Waist and hip circumference. Timepoint: Before and after the intervention. Method of measurement: Tape metre (cm).;Liver enzymes (alanine aminotransferase, aspartate aminotransferase and gamma glutamyl transferase). Timepoint: Before and after the intervention. Method of measurement: Colorimetric enzymatic method (Pars Azmun).;Lipid profile (HDL-c, LDL-c, TG, total cholesterol and VLDL). Timepoint: Before and after the intervention. Method of measurement: Colorimetric enzymatic method (Pars Azmun).;Serum homocysteine. Timepoint: Before and after the intervention. Method of measurement: ELISA.;Serum levels of C-reactive protein. Timepoint: Before and after the intervention. Method of measurement: ELISA.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeynab Porasgari

Islamic Azad University

porasgarizeynab@yahoo.com+98 911 196 0775

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026